TenaRx Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

TenaRx General Information

Description

Developer of selective CLK/DYRK kinase inhibitors designed to reprogram cellular fate and master-regulate immune, metabolic, and neurodevelopmental pathways. The company is currently operating in Stealth Mode.

Contact Information

Website
www.tenarx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6555 Nancy Ridge Drive
  • Suite 300
  • San Diego, CA 92121
  • United States
Primary Industry
Decision/Risk Analysis
Other Industries
Drug Discovery
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 6555 Nancy Ridge Drive
  • Suite 300
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TenaRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Mar-2026 Completed Stealth
To view TenaRx’s complete valuation and funding history, request access »

TenaRx Patents

TenaRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250206746-A1 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof Pending 22-Dec-2023
US-12661352-B2 Combination therapy with clk/dyrk inhibitors and bcl2 inhibitors to treat leukemia Active 12-Oct-2023
US-20250375442-A1 Combination therapy with clk/dyrk inhibitors and bcl2 inhibitors to treat leukemia Active 12-Oct-2023
US-12729205-B2 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof Active 23-Jun-2022
US-20240002391-A1 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof Active 23-Jun-2022 C07D487/04
To view TenaRx’s complete patent history, request access »

TenaRx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Polar Light Ventures Venture Capital Minority
To view TenaRx’s complete investors history, request access »

TenaRx FAQs

  • When was TenaRx founded?

    TenaRx was founded in 2025.

  • Where is TenaRx headquartered?

    TenaRx is headquartered in San Diego, CA.

  • What industry is TenaRx in?

    TenaRx’s primary industry is Decision/Risk Analysis.

  • Is TenaRx a private or public company?

    TenaRx is a Private company.

  • What is TenaRx’s current revenue?

    The current revenue for TenaRx is .

  • Who are TenaRx’s investors?

    Polar Light Ventures has invested in TenaRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process